Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(BN) Peregrine Plummets Most Ever After Unreliable Cancer Trial
(2)
+------------------------------------------------------------------------------+
Peregrine Plummets Most Ever After Unreliable Cancer Trial (2)
2012-09-24 20:13:41.527 GMT
(Updates with closing shares in the second paragraph.)
By Elizabeth Lopatto
Sept. 24 (Bloomberg) -- Peregrine Pharmaceuticals Inc.
plunged the most ever after the biotechnology company said the
survival rates from its lung cancer study reported earlier this
month were unreliable.
Peregrine declined 78 percent to $1.16 at the close in New
York, the biggest drop since April 1994. The shares of the
Tustin, California-based company had more than quadrupled in the
past 12 months through Sept. 21.
Peregrine soared 47 percent on Sept. 7 after the company
said non-small cell lung cancer patients who took the
drugmaker’s experimental bavituximab lived twice as long as
those on placebo. Peregrine said in a statement today that it
“discovered major discrepancies” between patient test results
and treatment code assignments by the independent contractor
responsible for the distribution of the medicine in the study.
“Today’s news comes as a shock and we believe represents a
major blow to confidence in the bavituximab program,” Joseph
Pantginis, a New York-based analyst for Roth Capital Partners,
wrote in a note to investors. “The level of uncertainty
surrounding the stock at this point is a major hurdle needing to
be addressed.”
Pantginis downgraded the stock to neutral, and lowered his
price target to 70 cents from $9.
“Investors should not rely on previously reported clinical
data,” Peregrine said in the statement. Christopher Keenan, a
company spokesman, declined to comment beyond the release.
For Related News and Information:
Health stories from the U.S.: TNI US HEA BN <GO>
Bloomberg drug data: BDRG <GO>
For health policy stories: TNI US HCP BN <GO>
Top stories about science: TNI SCIENCE WWTOP <GO>
Top health stories: HTOP <GO>
Drug Patent Expirations: DRGEXP <GO>
--Editors: Bruce Rule, Romaine Bostick
To contact the reporter on this story:
Elizabeth Lopatto in New York at +1-212-617-4016 or
elopatto@bloomberg.net.
To contact the editor responsible for this story:
Reg Gale at 212-617-2563 or rgale5@bloomberg.net.
Ambient Corporation Reports Results for the Second Quarter of 2012
http://ih.advfn.com/p.php?pid=nmona&article=54284727
(BFW) Peregrine Pharma PT Cut by 92% at Roth on ‘Major Uncertain
ty’
+------------------------------------------------------------------------------+
Peregrine Pharma PT Cut by 92% at Roth on ‘Major Uncertainty’
2012-09-24 13:27:41.152 GMT
By Catherine Larkin
Sept. 24 (Bloomberg) -- Peregrine Pharma cut to neutral
from buy and removed from focus list at Roth; PT lowered to 70c
from $9.
* News of third-party coding discrepancies with PPHM study is
“major blow to confidence” in experimental cancer drug
bavituximab: Roth analyst Joseph Pantginis in note
* Roth sees “major uncertainty surrounding the stock,” will
step to sidelines until there is more visibility on extent
of impact to previously announced study results
* NOTE: PPHM down 85% pre-market after earlier saying it found
discrepancies between test results and treatment code
assignments in Phase 2 study {NSN MAURCT6KLVTB <GO>}
Link to Company News:{PPHM US <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Catherine Larkin in Indianapolis at +1-703-599-6123 or
clarkin4@bloomberg.net
To contact the editor responsible for this story:
Joanna Ossinger at +1-212-617-7789 or
jossinger@bloomberg.net
all of this has absolutely NOTHING to do with IDOI nor for that matter any of the other 1000's of stocks out there. Just more sarcasm and innuendo sprinkled with speculation IMO.
http://investorshub.advfn.com/uimage/uploads/2012/8/24/jvmerSHOES-popup.jpg
Security chief caught with gun at airport
http://www.3news.co.nz/Security-chief-caught-with-gun-at-airport/tabid/417/articleID/270101/Default.aspx
TSA Weapons Are Hilarious to Play With, Especially in GIF Form
http://blogs.browardpalmbeach.com/pulp/2012/09/tsa.php
IDO Security's MagShoe Makes List of Top Innovations Developed in Israel
http://www.finanznachrichten.de/nachrichten-2012-04/23374928-ido-security-s-magshoe-makes-list-of-top-innovations-developed-in-israel-256.htm
AMBT Short Interest
Settlement Date
Short Interest
Avg Daily Share Volume
Days To Cover
8/31/2012
278,915
9,707
28.733388
Read more: http://www.nasdaq.com/symbol/ambt/short-interest#ixzz26e5WUoHT
IDO Security’s world-class manufacturing capabilities are complemented by our global network of distributors and system integrators, offering regional demonstrations, sales, implementation and support around the world. Our partners are hand-selected for their proven track records and long-term experience in the security and loss prevention markets.
http://magshoe.info/partners/index.php
PARTNERS
IDO Security (IDOI 0.25 ?1.01%)’s world-class manufacturing capabilities are complemented by our global network of distributors and system integrators, offering regional demonstrations, sales, implementation and support around the world. Our partners are hand-selected for their proven track records and long-term experience in the security and loss prevention markets.
http://www.idosecurityinc.com/about-ido-security/partners/
IDOI - Good Due Diligence !
IDO Security MagShoe - Shoes-On Weapons Detection
http://www.flickr.com/photos/magshoe/sets/72157629589835041/
http://www.slideshare.net/idosecurityinc/ido-security-magshoe-shoeson-weapons-detection
IDO Security Presenting MagShoe at ASIS Annual Seminar & Exhibit in Philadelphia, Pennsylvania With Its New Distributor Shergroup Ltd
http://www.equities.com/news/news-headline-story?dt=2012-09-07&val=459721&d=1&cat=headline
IDO Security's MagShoe 3G Presenting at GPEC Expo 2012 in Leipzig, Germany
http://uspolitics.einnews.com/pr_news/114278735/ido-security-s-magshoe-3g-presenting-at-gpec-expo-2012-in-leipzig-germany
Amended Current report filing (8-K/A)
http://ih.advfn.com/p.php?pid=nmona&article=54095425
Print
Alert
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 14, 2012
AMBIENT CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
001-35259
98-0166007
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
7 WELLS AVENUE, SUITE 11, NEWTON, MASSACHUSETTS, 02459
(Address of principal executive offices, including Zip Code)
617- 332-0004
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Explanatory Note
This Amendment No. 1 on Form 8-K/A amends and restates the Current Report on Form 8-K filed by Ambient Corporation (the “Company”) with the Securities and Exchange Commission (the “SEC”) on August 15, 2012 (the “Original Form 8-K”) to revise certain of the disclosures contained therein. Namely, the Original Form 8-K is being revised to provide an estimated time frame as to when the Company anticipates filing restated financial statements relating to the accounting treatment of previously issued convertible notes and warrants and to provide an estimate of the amount of adjustments involved as well as certain other revisions. Furthermore, this Amendment No. 1 on Form 8-K/A provides more detail relating to the accounting errors discovered, and also describes changes to stock-based compensation that was not previously identified. Except for the changes described in this explanatory note, no other amendments to the Original Form 8-K are made by this Form 8-K/A.
SECTION 2 –FINANCIAL INFORMATION
Item 2.02 Results of Operation and Financial Condition.
Ambient Corporation (the “ Company ”) anticipates revenues of approximately $10.0 million and $23.2 million, respectively, for the three and six months ended June 30, 2012 as compared to approximately $15.9 million and $27.9 million, respectively, for the corresponding periods in 2011. The Company also anticipates a loss from operations of approximately $1.5 million for the three and six month periods ending June 30, 2012 as compared to income from operations of approximately $2.8 million and $4.1 million, respectively, for the corresponding periods in 2011 (as restated). The increase in loss from operations is mainly attributable to lower sales volumes and increased investment in sales and marketing and research and development. The Company also anticipates net loss of approximately $1.2 million and $1.4 million, respectively, for the three and six month periods ending June 30, 2012 as compared to net income of approximately $3.6 million and $6.0 million, respectively, for the corresponding periods in 2011 (as restated). The summary information relating to results of the three and six month periods ending June 30, 2012 and 2011 are estimates and preliminary and are subject to change pending the Company's final reviews.
SECTION 4 – MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
In connection with the preparation of the quarterly report on Form 10-Q for the three months ended June 30, 2012, management of the Company concluded that certain previously filed financial statements did not properly account for embedded derivative features of certain historical debt and equity securities issued by the Company, which are described in detail below.
Convertible Debt : Certain historical convertible notes (the “Notes”) issued by the Company were previously recorded at their discounted face value. The discounts were comprised of both beneficial conversion features associated with the Notes and the fair value of warrants issued in connection with the Notes. However, the Notes contained certain features, including anti-dilution price protection and others that, in accordance with ASC-815, Derivatives and Hedging (“ASC 815”), should have been bifurcated from the host contract and accounted for as a derivative instrument (the “Embedded Derivatives”). Such Embedded Derivatives are recorded as a separate liability at their fair value on the date of issuance, and as a corresponding discount to the Notes which is amortized to interest expense over the expected term of the Notes. Changes in the fair values of these instruments require adjustments to the amount of the liabilities recorded on the Company’s balance sheet, and the corresponding gain or loss is required to be recorded in the Company’s statement of operations, as long as the Notes are outstanding.
--------------------------------------------------------------------------------
Warrants: In connection with issuing the aforementioned Notes, as well as in connection with other financing transactions, the Company issued warrants to purchase common stock (collectively, the “Warrants”). The Company had previously classified the value of Warrants as equity. After further review, the Company determined that these instruments should have been classified as liabilities in accordance with ASC 815, due primarily to an anti-dilution price protection feature contained in such warrants. Changes in the fair values of these instruments require adjustments to the amount of the liabilities recorded on the Company’s balance sheet, and the corresponding gain or loss is required to be recorded in the Company’s statement of operations.
Stock-based Compensation: The Company had previously used volatility assumptions based on the historical volatility of the Company's common stock, which, based on the historical trading activity of the stock, resulted in inflated volatilities that were not necessarily indicative of the expected volatility and substantially higher than other peer-industry companies. Upon further review of the volatility assumption, the Company determined that an expected volatility based on the volatilities of its industry peer group is a more appropriate sustainable volatility. Such an approach was used to determine appropriate volatility assumptions for valuation purposes of the Embedded Derivatives and Warrants. As a result, volatility assumptions are lower than those previously used which reduced stock-based compensation.
Based on the recommendation of management, on August 14, 2012, our audit committee and board of directors determined, after discussions with our current independent accountants, PricewaterhouseCoopers LLP, and our prior independent accountants, Rotenberg, Meril Solomon Bertiger & Guttilla, P.C., that our audited financial statements for the years ended December 31, 2003 through 2011 and unaudited interim financial statements for the quarters ended March 31, June 30, and September 30 for such years, and our unaudited interim financial statements for the quarter ended March 31, 2012 should not be relied upon. In addition, any press releases containing financial information for such periods should not be relied upon.
The Company expects to restate its financial results for the fiscal years ended December 31, 2007 through 2011, as well as the quarters in the fiscal years ended December 31, 2010 and 2011 and the first quarter of fiscal 2012. The Company will include its restated audited annual financial statements in a Form 10-K/A for the fiscal year ended December 31, 2011 and its restated unaudited interim financial statements in a Form 10-Q/A for the quarterly period ended March 31, 2012. The Form 10-K/A will also include restated quarterly financial information for each of the quarterly periods in the fiscal years ended December 31, 2010 and 2011. The Company believes that these amended and restated filings will contain disclosures that are adequate and appropriate to restate the relevant financial information for the accounting adjustments noted with respect to previous reporting periods. The board of directors and audit committee unanimously approved, authorized and directed such restatements to be filed as soon as practicable. The Company anticipates filing the restated 10-K/A for the fiscal year ended December 31, 2011 and the 10-Q/A for the quarterly period ended March 31, 2012 prior to September 30, 2012. The Company also expects to file its quarterly report on Form 10-Q for the three and six month periods ending June 30, 2012 prior to September 30, 2012.
Expected Impact of the Restatement
The estimated adjustments to the Company’s balance sheets and statements of operations are summarized in the tables below. The Company is still in the process of completing its review, and, therefore, the estimated adjustments described below are preliminary. While the Company expects to report the estimated adjustments described below, there can be no assurance that the final adjustments that are made as part of the restatement will not differ materially from the estimated adjustments.
The adjustments are primarily related to complex accounting requirements of certain characteristics of the Notes and Warrants (and to a lesser extent, stock-based compensation) that require the recording of debt discounts and related amortization, mark-to-market adjustments in the fair value of Warrants and Embedded Derivatives and gains or losses associated with the extinguishment of debt under certain circumstances. As the errors were non-cash in nature, the adjustments did not impact total cash flow from operating, investing or financing activities.
As a result of these cumulative adjustments, as of December 31, 2011, accumulated deficit is expected to increase from $138.7 million to approximately $222.4 million and additional paid in capital is expected to increase from $155.7 million to approximately $238.8 million. However, at December 31, 2011, the net impact of the cumulative adjustments associated with these aforementioned adjustments has a relatively small impact to overall stockholders’ equity. Since all of the Notes were either paid down or converted by early 2010 and many of the Warrants were either exercised or expired by the end of 2011, the estimated impact of accounting for these instruments in 2012 and for future periods is expected to be minimal.
--------------------------------------------------------------------------------
The tables below summarize the estimated impact on the Company’s balance sheets for the years ended December 31, 2007 through December 31, 2011 and for the quarter ended March 31, 2012:
Year Ended December 31, 2007
Year Ended December 31, 2008
Year Ended December 31, 2009
(In thousands)
As
Reported
Total Estimated Adj.
Preliminary Restated
As
Reported
Total Estimated Adj.
Preliminary Restated
As
Reported
Total Estimated Adj.
Preliminary Restated
Deferred financing costs
$
898
$
(369
)
$
529
$
-
$
-
$
-
$
-
$
-
$
-
Total assets
2,816
(369
)
$
2,447
10,622
-
10,622
3,393
-
3,393
Convertible debt, net of discounts
2,672
(794
)
1,878
754
382
1,136
9,816
(3,099
)
6,717
Warrant and derivative liabilities
-
7,190
7,190
-
17,099
17,099
-
95,827
95,827
Total liabilities
4,281
6,397
10,678
3,168
17,481
20,649
12,928
92,728
105,656
Additional paid-in capital
113,434
(17,991
)
95,444
133,643
(26,839
)
106,804
130,898
2,967
133,865
Accumulated deficit
(114,702
)
11,225
(103,477
)
(125,996
)
9,358
(116,638
)
(140,242
)
(95,694
)
(235,936
)
Total stockholders' (deficit) equity
(1,465
)
(6,766
)
(8,231
)
7,454
(17,481
)
(10,027
)
(9,535
)
(92,728
)
(102,263
)
Total liabilities and stockholders' equity
$
2,816
$
(369
)
2,447
$
10,622
$
-
$
10,622
$
3,393
$
-
$
3,393
(In thousands)
Year Ended December 31, 2010
Year Ended December 31, 2011
Quarter Ended March 31, 2012
As
Reported
Total Estimated Adj.
Preliminary Restated
As
Reported
Total Estimated Adj.
Preliminary Restated
As
Reported
Total Estimated Adj.
Preliminary Restated
Deferred financing costs
$
-
$
-
$
-
$
389
$
-
$
389
$
-
$
-
$
-
Total assets
10,573
-
10,573
21,874
-
21,874
22,512
-
22,512
Convertible debt, net of discounts
-
-
-
-
-
-
-
-
-
Warrant and derivative liabilities
-
4,353
4,353
-
670
670
-
780
780
Total liabilities
4,437
4,353
8,790
5,008
670
5,678
4,839
780
5,619
Additional paid-in capital
149,748
84,929
234,677
155,707
83,075
238,782
156,647
82,787
239,434
Accumulated deficit
(143,428
)
(89,282
)
(232,710
)
(138,658
)
(83,744
)
(222,402
)
(138,991
)
(83,567
)
(222,558
)
Total stockholders' equity
6,136
(4,353
)
1,783
16,866
(670
)
16,197
17,673
(780
)
16,893
Total liabilities and stockholders' equity
$
10,573
$
-
$
10,573
$
21,874
$
-
$
21,874
$
22,512
$
-
$
22,512
--------------------------------------------------------------------------------
The tables below summarize the estimated impact on the Company’s statements of operations for the years ended December 31, 2007 through December 31, 2011 and for the quarter ended March 31, 2012:
Year Ended December 31, 2007
Year Ended December 31, 2008
Year Ended December 31, 2009
(In thousands)
As Reported
Total Estimated Adj.
Preliminary Restated
As Reported
Total Estimated Adj.
Preliminary Restated
As Reported
Total Estimated Adj.
Preliminary Restated
Cost of goods sold
$
1,806
$
-
$
1,806
$
9,942
$
-
$
9,942
$
1,836
$
-
$
1,836
Operating expenses
7,687
(48
)
7,639
7,951
(87
)
7,864
9,608
(346
)
9,262
Operating (loss) income
(7,228
)
48
(7,180
)
(5,271
)
87
(5,184
)
(9,251
)
346
(8,905
)
Other (loss) income:
Interest expense, net
(1,102
)
(1,968
)
(3,071
)
(3,116
)
1,046
(2,070
)
(4,963
)
4,376
(587
)
Amortization of debt discount, beneficial conversion feature and deferred financing costs
(7,600
)
2,618
(4,982
)
-
(4,671
)
(4,671
)
-
(6,604
)
(6,604
)
Changes in fair value of derivatives
-
6,797
6,797
-
68
68
-
(108,597
)
(108,597
)
(Gain) loss on extinguishment of debt
-
-
-
(2,789
)
1,604
(1,185
)
-
5,426
5,426
Other income (loss)
174
1
175
(118
)
-
(118
)
(32
)
-
(32
)
Total other (loss) income
(8,528
)
7,447
(1,081
)
(6,023
)
(1,954
)
(7,977
)
(4,995
)
(105,398
)
(110,393
)
Net (loss) income
$
(15,756
)
$
7,495
$
(8,261
)
$
(11,294
)
$
(1,867
)
$
(13,161
)
$
(14,246
)
$
(105,052
)
$
(119,306
)
During 2009, the Company's stock price appreciated significantly throughout the year. As a result, the fair value of the Embedded Derivatives and Warrants increased substantially, and the Company recorded a loss of approximately $108.6 million for the year ended December 31, 2009.
Year Ended December 31, 2010
Year Ended December 31, 2011
Quarter Ended March 31, 2012
(In thousands)
As Reported
Total Estimated Adj.
Preliminary Restated
As Reported
Total Estimated Adj.
Preliminary Restated
As Reported
Total Estimated Adj.
Preliminary Restated
Cost of goods sold
$
12,023
$
-
$
12,023
$
35,490
$
(217
)
$
35,273
$
7,519
$
(44
)
$
7,475
Operating expenses
11,553
(270
)
11,283
21,861
(1,958
)
19,903
6,138
(324
)
5,814
Operating (loss) income
(3,218
)
270
(2,948
)
4,955
2,175
7,130
(408
)
368
(40
)
Other (loss) income:
Interest expense, net
(214
)
184
(30
)
19
-
19
2
-
2
Amortization of debt discount, beneficial conversion feature and deferred financing costs
-
-
-
-
-
-
-
-
-
Changes in fair value of derivatives
-
8,045
8,045
-
3,362
3,362
-
(191
)
(191
)
(Gain) loss on extinguishment of debt
252
(2,086
)
(1,835
)
-
-
-
-
-
-
Other income (loss)
(6
)
-
(6
)
-
-
-
73
-
73
Total other (loss) income
32
6,142
6,174
19
3,362
3,381
75
(191
)
(116
)
Net (loss) income
$
(3,186
)
$
6,412
$
3,226
$
4,770
$
5,537
$
10,307
$
(333
)
$
177
$
(156
)
Management has not yet completed its assessment of the impact, if any, that these accounting errors and adjustments may have on the effectiveness of the Company’s disclosure controls and procedures and its internal control over financial reporting, including whether or not a material weakness exists.
This Current Report on Form 8-K contains forward-looking statements, including forward-looking statements relating to the Company's financial results for the three and six months ended June 30, 2012. These statements are based on management's current expectations and involve a number of risks and uncertainties, including risks described in our filings with the Securities and Exchange Commission. The Company's actual results may differ materially from the Company's anticipated or expected results and the results in the forward-looking statements.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Exhibit Description
99.1 Press release issued by Ambient Corporation dated as of August 15, 2012 (previously filed)
IDOI - Good Due Diligence !
IDO Security MagShoe - Shoes-On Weapons Detection
http://www.flickr.com/photos/magshoe/sets/72157629589835041/
http://www.slideshare.net/idosecurityinc/ido-security-magshoe-shoeson-weapons-detection
IDO Security's MagShoe 3G Presenting at GPEC Expo 2012 in Leipzig, Germany
http://www.sys-con.com/node/2357381
U NEVER KNOW
Metal Detector Shoe Scanners
http://www.securitymetaldetector.net/Metal-Detector-Shoe-Scanners-s/49.htm
IDO Security's MagShoe
http://www.flickr.com/photos/magshoe/sets/72157629589835041/
CEOLIVE Investor Profiles - IDO Security (OTCBB: IDOI)
http://vimeo.com/46053870
IDO Security MagShoe - Shoes-On Weapons Detection
http://www.slideshare.net/idosecurityinc/ido-security-magshoe-shoeson-weapons-detection
Mar 15, 2012 – IDO Security (IDOI.OB) develops solutions for shoes-on weapons metal detection – filling a critical void in the market by extending security ...
IDO Security Presenting MagShoe at ASIS Annual Seminar & Exhibit in Philadelphia, Pennsylvania With Its New Distributor Shergroup Ltd.
http://www.equities.com/news/news-headline-story?dt=2012-09-07&val=459721&d=1&cat=headline
Another new product is called the Magshoe. People step on it and the machine reads out how much metal content is in a person’s shoe, sock or in the cuff of their pants. Mahoney said their first customer is the U.S. Mint in San Francisco. They plan to use it to prevent theft.
The device came about because of their relationship with a company in Israel. They asked JEI if they could build and sell the device in the U.S. because it’s cheaper to build here than there. The plan is to sell the Magshoe to the same agencies who buy the recording equipment in addition to prisons, court houses, airports, and military command centers. All of these agencies face the problem of people trying to smuggle in weapons or contraband. Installation of the device would mean that people would no longer be required to remove their shoes when entering a secure area.
Mahoney said that while the downturn in the economy is affecting them just as it is other businesses, they continue to explore ” new designs, new ideas, (and) new marketing that will grow our business and allow us to hire more people.”
It’s a growing market,” said Mahoney, “and we are a favorite among U.S. military, Federal Law Enforcement and Local law Enforcement.”
Contact Dawn Hodson at 530-344-5071 or dhodson@mtdemocrat.net. Follow @DHodsonMtDemo on Twitter.
http://www.mtdemocrat.com/news/jei-builds-voice-recording-systems/
IDO Security Presenting MagShoe at ASIS Annual Seminar & Exhibit in Philadelphia, Pennsylvania With Its New Distributor Shergroup Ltd.
http://www.marketwatch.com/story/ido-security-presenting-magshoe-at-asis-annual-seminar-exhibit-in-philadelphia-pennsylvania-with-its-new-distributor-shergroup-ltd-2012-09-07
IDO Security Presenting MagShoe at ASIS Annual Seminar & Exhibit in Philadelphia, Pennsylvania With Its New Distributor Shergroup Ltd.
http://www.marketwatch.com/story/ido-security-presenting-magshoe-at-asis-annual-seminar-exhibit-in-philadelphia-pennsylvania-with-its-new-distributor-shergroup-ltd-2012-09-07
IDO Security Presenting MagShoe at ASIS Annual Seminar & Exhibit in Philadelphia, Pennsylvania With Its New Distributor Shergroup Ltd
http://finance.yahoo.com/news/ido-security-presenting-magshoe-asis-140644345.html
Ido Security (IDOI)0.27 + 0.02 (+8.00%)Volume: 115,856
@ 3:57:37 PM ET
RESULTS OF OPERATIONS,(Up Approx 25,000% from the corresponding periods in 2011 )
COMPARISON OF THE SIX AND THREE MONTHS ENDED JUNE 30, 2012 TO THE SIX AND THREE MONTHS ENDED JUNE 30, 2011
Revenues and costs of goods sold - Revenues for the six and three months ended June 30, 2012 were $285,480 ( Approx +1500%) and $80,916,(Approx +25,000%) respectively, compared to $19,486 and $325 for the corresponding periods in 2011. All revenues were derived from sales of our MagShoe? device.
http://biz.yahoo.com/e/120820/idoi10-q.html
Ya Right
LOL